Seaport Therapeutics’ $225 Million Series B Financing Round

Wilson Sonsini Goodrich & Rosati advised General Atlantic on patent matters related to the transaction.Seaport Therapeutics (Seaport), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here